← Back to patent-cliff list
NNC-0165-1875
Tier C — Watch / tradeNNC-0165-1875
-
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type
Targets：NPYRs
Indications (approved)：Obesity, Overweight
Regional status
US
Phase II
2021-07-15
EU
-
China
-
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of NNC-0165-1875?
Approved indications include: Obesity, Overweight.
When does the NNC-0165-1875 patent expire?
No public expiry year is available for NNC-0165-1875 yet; this page updates once verified.
How do I get a quote for NNC-0165-1875 intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-06